Novel phenotype classification of hidradenitis suppurativa based upon clinical, ultrasonographical and analytical parameters. Part 2

被引：0
|
作者：
Bittencourt, Flavia [1 ]
Agut-Busquet, Eugenia [1 ]
Vidal, Silvia [2 ]
Canto, Elisabet [2 ]
Puig, Lluis [1 ]
Vilarrasa, Eva [1 ]
机构：
[1] Hosp Santa Creu & St Pau Univ Autonomade, Dermatol Dept, Barcelona, Spain
[2] Inst Recerca Hosp Santa Creu & St Pau, Expt Immunol, Barcelona, Spain
来源：
EXPERIMENTAL DERMATOLOGY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
81
引用
收藏
页码：52 / 52
页数：1
相关论文
共 18 条
  • [1] Novel phenotype classification of hidradenitis suppurativa based upon clinical, ultrasonographical and analytical parameters. Part 1
    Vilarrasa, Eva
    Agut-Busquet, Eugenia
    Vidal, Silvia
    Canto, Elisabet
    Puig, Luis
    Bittencourt, Flavia
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 48 - 48
  • [2] Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity
    Grand, D.
    Frew, J. W.
    Navrazhina, K.
    Krueger, J. G.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (04) : 688 - 696
  • [3] Novel nicastrin mutation in hidradenitis suppurativa-Dowling-Degos disease clinical phenotype: more than just clinical overlap?
    Garcovich, S.
    Tricarico, P. M.
    Nait-Meddour, C.
    Giovanardi, G.
    Peris, K.
    Crovella, S.
    Boniotto, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : 758 - 759
  • [4] HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
    Kimball, A. B.
    Sobell, J. M.
    Zouboulis, C. C.
    Gu, Y.
    Williams, D. A.
    Sundaram, M.
    Teixeira, H. D.
    Jemec, G. B. E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (06) : 989 - 994
  • [5] Efficacy results using a novel hidradenitis suppurativa endpoint, HiSCR (hidradenitis suppurativa clinical response), from the placebo-controlled phase of a phase 2 adalimumab study
    Jemec, Gregor
    Sobell, Jeffrey
    Scheinfeld, Noah
    Sood, Sarika
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB42 - AB42
  • [6] Efficacy Results Using a Novel Hidradenitis Suppurativa Endpoint, Hiscr (Hidradenitis Suppurativa Clinical Response), From The Placebo-Controlled Phase of a Phase 2 Adalimumab Study
    Scheinfeld, N. S.
    Sobell, J. M.
    Gu, Y.
    Sood, S.
    ANNALS OF EMERGENCY MEDICINE, 2013, 62 (04) : S151 - S151
  • [7] A comprehensive, patient-based approach to the clinical and molecular classification of complex, syndromic hidradenitis suppurativa phenotypes: a practical, translational framework
    Moltrasio, Chiara
    Genovese, Giovanni
    Crovella, Sergio
    Tricarico, Paola M.
    Boniotto, Michele
    Garcovich, Simone
    Marzano, Angelo V.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 43 - 44
  • [8] NOVEL CLASSIFICATION OF HYPOXANTHINE-PHOSPHORIBOSYLTRANSFERASE-DEFICIENCY - A CORRELATION BETWEEN THE CLINICAL PHENOTYPE, BIOCHEMICAL PARAMETERS AND FIBROBLAST PROLIFERATION IN SELECTIVE MEDIA
    HELD, KR
    WILLERS, I
    SINGH, S
    GOEDDE, HW
    CLINICAL GENETICS, 1983, 23 (03) : 212 - 213
  • [9] STRAIN-LIFE CURVES OF STEELS AND METHODS FOR DETERMINING THE CURVE PARAMETERS. PART 2. METHODS BASED ON THE USE OF ARTIFICIAL NEURAL NETWORKS
    Troshchenko, V. T.
    Khamaza, L. A.
    Apostolyuk, V. A.
    Babich, Yu. N.
    STRENGTH OF MATERIALS, 2011, 43 (01) : 1 - 14
  • [10] A novel seizure quality index based on ictal parameters for optimizing clinical decision-making in electroconvulsive therapy. Part 2: Validation
    Kranaster, Laura
    Jennen-Steinmetz, Christine
    Sartorius, Alexander
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2019, 269 (07) : 859 - 865
12